At the SAP Sapphire 2025 conference, the company announced a series of updates to its SuccessFactors suite, SAP’s flagship HCM and HR platform. These updates reflect both incremental progress for ...
Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results